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Abstract
Cold plasma generated in an open environment with a temperature nearly 
around room temperature has recently been a topic of great importance. It has 
unlocked the door of plasma application in a new direction: biomedical applications. 
Cold atmospheric pressure (CAP) plasma comprises various neutral and charged 
reactive species, UV radiations, electric current/fields etc., which have several 
impactful effects on biological matter. Some of the significant biological effects of 
CAP plasma are inactivation of microorganism, stimulation of cell proliferation 
and tissue regeneration, destruction of cells by initializing apoptosis etc. Although 
the detailed mechanism of action of plasma on biomaterials is still not completely 
understood, some basic principles are known. Studies have indicated that the 
reactive oxygen species and nitrogen species (ROS, RNS) play a crucial role in the 
observed biological effects. In this perspective, this chapter first provides a brief 
discussion on the fundamentals of CAP plasma and its generation methods. Then 
a discussion on the optical diagnostics methods to characterize the plasma is pro-
vided. Optical emission spectroscopy (OES) is used to identify the reactive species 
and to measure their relative concentration. Other important plasma parameters 
such as gas temperature, electron/excitation temperature and electron density mea-
surement methods using OES have also been discussed. Then a discussion on the 
application of CAP plasma in biomedical field is provided. A thorough understand-
ing of biochemical reaction mechanisms involving highly reactive plasma species 
will further improve and extend CAP plasma technology in biomedical applications.
Keywords: Cold atmospheric plasma, plasma jet, dielectric barrier discharge,  
reactive oxygen and nitrogen species, plasma medicine, wound healing,  
cancer therapy
1. Introduction
In physical sciences, the term “plasma” often refers to the fourth state of mat-
ter consisting of electrons, ions and neutral particles; while in biology, it refers to 
the yellowish non-cellular liquid portion of the blood. The Nobel prize-winning 
American chemist Irving Langmuir first used the term plasma in 1927 to an ionized 
gas - an electrified fluid carrying electrons and ions, in analogy to the biological 
plasma carrying blood corpuscles, germs etc. Despite this historical connection, 
there had been no real correlation between the two plasmas until the emergence of 
the plasma medicine field recently [1].
Plasma Science and Technology
2
Plasma can exist in a variety of forms and can be created in several ways. More 
than 99% of the visible universe is considered to be in the plasma state. The twin-
kling of stars, nebulas, auroras in the night sky are some examples of plasma that 
we observe away from us, and so is our Sun. On the other hand, flashes of lightning, 
fluorescent tubes, neon signs along our city streets are some other plasma examples 
that we encounter in our everyday life. Plasma can be classified in different ways 
based on thermodynamic equilibrium, ionization degree, density etc. Based on 
the thermal equilibrium between the electrons and the heavy particles, plasma 
can be categorized into thermal or high temperature plasma and nonthermal or 
cold plasma [2]. The distinction between thermal and nonthermal plasmas is very 
important in the context of this chapter. In all plasmas produced by applying an 
external electric field, the energy transfer to the electrons is much faster than that to 
the heavier ions. Due to their very high mobility, electrons have the opportunity to 
heat up to several thousands of degrees of Kelvin before the surrounding environ-
ment heats up or even without heating them at all. In thermal plasma, the electrons 
and heavy particles (neutrals and ions) reach a local thermodynamically equilib-
rium state, i.e., energy transfer from electrons to the heavy particles equilibrates the 
energy transfer from heavy particles to the environment, and all the species in the 
environment remain at almost the same temperature. Because of this, this type of 
plasma is also called equilibrium plasma. Thermal plasma can reach a temperature 
up to 108 K, as found in the solar core. On the other hand, in nonthermal plasma, 
cooling of heavier particles is more efficient than the energy transfer from electrons 
to them, and the gas temperature remains low. Therefore nonthermal plasma is also 
called non-equilibrium plasma or cold plasma.
With the advent of atmospheric pressure plasma discharges in the early 1990s, 
various industrial and environmental applications that do not require low pressure 
operating conditions became possible [3]. Among these, the use of low-temperature 
atmospheric pressure plasma for biomedical application took center stage. The abil-
ity of these cold atmospheric pressure (CAP) plasma discharges to produce enhanced 
gas phase chemistry at low gas temperature has led to their widespread application 
in fields that require low temperatures, such as biomedical applications and material 
processing [4]. In recent years, different devices have been designed to generate cold 
plasma in atmospheric pressure and have been investigated for their ability to use in 
biomedical applications [5]. It is demonstrated that CAP plasma could interact with 
organic substances without causing any electrical/thermal damage. The early results 
have indicated the great potential of these CAP plasma devices for biomedical appli-
cations. These devices can produce plasma at nearly room temperature (less than 
40°C) at the contact zone, which is essential for direct application on the human or 
animal body as well as for sterilization of some medical devices [6]. Figure 1 shows a 
typical photograph of a cold plasma jet extending out of a 7 mm quartz tube.
In the mid-1990s, a few researchers, for the very first time, demonstrated the 
efficient bactericidal property of the CAP plasma. This has opened up a new field 
of research in science and technology, combining plasma physics and biology called 
plasma medicine. Since then, CAP plasma devices have been successfully utilized in 
various applications ranging from sterilization to wound healing to killing cancer 
cells [3, 7]. From the very beginning, it was expected that the reactive species gener-
ated by the CAP plasma play a crucial role in the observed biological effects. Even 
if many details regarding the mechanism of interaction of plasma with biological 
matter are still not clear, some basic principles are known, and our depth of knowl-
edge is growing very fast in this field. By the beginning of the second decade of the 
2000s, clinical trials on patients started with some success [8]. Several applications 
have reached the clinical trial stage, and some of the CAP plasma devices have 
already been certified as medical devices. Woedkte et al. list three clinical trials 
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using CAP plasma sources conducted in Germany, and two devices got CE mark-
ing as medical devices in 2013 [9]. Another device named SteriPlas (Adtec Ltd., 
London, UK) is the latest one to be certified for use as a medical device [10]. Several 
other devices have been tested under experimental and laboratory environments 
and are expecting possible clinical use certification. In 2019, the Food & Drug 
Administration (FDA) in the USA also approved for their first clinical trials of CAP 
plasma for cancer treatment [11].
It should be pointed out here that the early studies on plasma application in the 
biomedical field were concentrated on the thermal effects of plasma [12]. One such 
successful application was argon plasma coagulation (APC). It has been used to cut 
tissue in endoscopic applications. These devices operate by heating the tissue using 
electric current. Therefore their effects are mainly thermal. On the other hand, cold 
plasma transfers little heat, and its effects are primarily nonthermal.
These remarkable achievements of CAP plasma applications took only about 
25 years from the initial discovery to the fundamental scientific investigation stage 
and finally to applications on actual patients.
In this chapter, we shall concentrate mainly on the nonthermal or cold plasmas 
produced at atmospheric pressure, their production methods, diagnostics, and 
their various applications in the biomedical field. After the introductory portion 
in Section 1, the fundamentals of nonthermal plasma is discussed in Section 2. 
Figure 1. 
Photograph of a CAP plasma jet.
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In Section 3, various CAP plasma generation methods will be discussed. These 
include dielectric barrier discharge (DBD), atmospheric pressure plasma jet 
(APPJ) and corona discharge. Then in Section 4, we shall discuss the diagnostics 
methods of CAP plasma. Due to the small size of the CAP plasma, generally 
passive, non-contact diagnostic methods are utilized for characterization. Optical 
emission spectroscopy (OES) is one such very popular non-invasive diagnostic 
tool for CAP plasma characterization. Then in Section 5, we shall discuss the 
interaction of CAP plasma with biomaterials and their biological effects. Section 6 
discusses various significant biomedical applications of CAP plasma ranging from 
sterilization to wound healing to killing cancers. The final section then summa-
rizes the application of CAP plasma technology in biomedical applications and 
their future outlook.
2. Fundamentals of nonthermal plasma
The term nonthermal plasma refers to a plasma that is not in thermodynamic 
equilibrium, meaning that the temperature of electrons, ions and neutrals are 
not equal. In this type of plasma, the electrons remain at a very high temperature 
(up to a few eV, 1 eV ≈ 11,600 K), whereas the temperature of heavy particles is 
quite low. Because of this reason, they are also termed as non-equilibrium or cold 
plasma. The high energetic electrons provide the unique reaction chemistry of 
the cold plasma by facilitating excitation, ionization and chemical dissociation 
of atoms and molecules at a very low gas temperature. The cold plasma gener-
ated at atmospheric pressure produces a myriad of reactive and charged species, 
including electrons, ions, free radicals, neutral or excited atoms, UV photons etc. 
These exciting properties of cold plasma have led to their extensive use in various 
technological fields such as material processing, environmental remediation, 
nanomaterial synthesis, textile industry, food processing and biomedical  
applications etc. [13].
Plasmas can be generated by supplying electrical energy to a gas in the form 
of an electric field. When the applied electric field between the two electrodes is 
high enough to initiate a breakdown, plasma is formed. Electrons can rapidly gain 
energy from the applied electric field because of their tiny mass and high mobility. 
Then they transmit the energy to the neutral atoms and molecules through colli-
sions, providing energy for ionization, excitation, dissociation and other chemical 
processes. Two types of collisions occur in plasmas [14]:
Elastic collisions: These type of collisions raise the kinetic energy of the neutral 
species but do not change their internal energies. They increase the temperature of 
the heavy particles.
Inelastic collisions: These type of collisions between electrons and heavy par-
ticles are excitative or ionizing. They modify the electronic structure of the neutral 
species. When the electronic energy is high enough, it can create excited species or 
ions. Most of the excited species of plasma have a very short lifetime. They come 
down to the ground state by emitting a photon. The metastable species are also 
excited states, but they can decay only by energy transfer through collisions as there 
are no allowed transitions. Hence, they have a longer lifetime. These collisions do 
not raise the temperature of heavy particles.
2.1 Paschen’s law
The voltage necessary to start a discharge in a gas between two electrodes is 
given by Paschen’s law. It is named after Freidrich Paschen, who discovered it 
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empirically in 1889. The breakdown voltage depends on the electrode spacing d and 
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Here, A and B are constants determined experimentally, and seg  is the secondary 
electron emission coefficient of the cathode. Figure 2 shows the dependence of 
breakdown voltage of various gases on the product of electrode spacing and pres-
sure. It is seen that for a constant electrode spacing, the voltage required to ionize a 
gas is high towards higher pressure, which implies that a narrow gap is necessary to 
have a reasonable breakdown voltage at atmospheric pressure.
2.2 Current-Voltage characteristics
The plasma behavior inside a discharge is determined by the values of current 
and voltage between the electrodes. A typical figure that almost every plasma physics 
textbook discusses is the current–voltage characteristic of a low-pressure (~ 1 mTorr) 
DC discharge, which describes different gas discharge regimes as shown in Figure 3. 
Arc discharged is characterized by a very high current and a low voltage between the 
anode and the cathode. Glow discharge occurs at a low current (typically in mA range) 
and a high voltage. The corona discharge is characterized by a very low current (few 
μA) and a very high voltage. For low-temperature atmospheric pressure applications, 
arc discharge is not acceptable as it produces a very high gas temperature. Therefore, 
a special setup is necessary to create a cold plasma and keep the plasma current low so 
that discharge remains in glow and corona regime.
Figure 2. 
Breakdown voltage in various gases as a function of the product of pressure, P and gap distance, d for plane 
parallel electrode.
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The necessary condition for a plasma to be suitable for biomedical application is 
that the plasma has to be produced at atmospheric pressure and the gas temperature 
has to be near room temperature to avoid thermal damage of biomaterials (tissue 
etc.) at the contact zone. For this purpose, the plasma needs to be near glow mode. 
However, glow discharge is generally produced at low pressure. At higher pressure, 
glow discharge is unstable, and a glow to arc transition can always occur. Therefore, 
a special electrode arrangement is required to maintain the discharge near glow 
and corona regime at atmospheric pressure. One general method of producing CAP 
plasma is to place a dielectric barrier between the two electrodes, and the resulting 
plasma is known as dielectric barrier discharge (DBD). The role of the dielectric 
is to limit the discharge current and thus keeps the plasma temperature low. The 
different types of CAP plasma generation methods are discussed in the next section.
3. Methods of CAP plasma production
Production of atmospheric pressure nonthermal plasma is quite challenging 
due to high electron-neutral collision frequency, and low applied electric field. 
Fortunately, several methods have been developed over the years to overcome these 
challenges. Different production methods have been reported to produce cold 
plasma in the open environment. These include Dielectric Barrier Discharge (DBD), 
Atmospheric Pressure Plasma Jet (APPJ), corona discharge etc. Several different 
working gases such as Helium, Argon, Nitrogen, Heliox (a mix of helium and oxy-
gen), air etc., are used to produce CAP plasma. This section gives a brief overview 
of the commonly used CAP plasma generation techniques.
3.1 Dielectric barrier discharge (DBD)
One of the most widely used techniques for generating CAP plasma is the 
dielectric barrier discharge (DBD) using alternating or pulsed electric field. As the 
name itself suggests, a dielectric cover is used at least at one of the two electrodes 
for producing the discharge. The function of the dielectric layer is to suppress 
the spark or arc transition by limiting the discharge current. DBDs are also called 
Figure 3. 
Current–voltage characteristics of a low pressure DC discharge showing transitions from Townsend to glow and 
arc discharge.
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“silent” discharges as it produces no sound during discharge. Typical electrode gap 
distance in a DBD varies from 0.1 mm to several centimeters. Different dielectric 
materials such as glass, quartz, ceramics and polymers etc., are used in DBDs. To 
avoid a spark or arc transition, sufficient breakdown strength of the dielectric 
layer is necessary for insulation of discharge current. But a thicker layer requires a 
higher voltage, so a compromise must be made here. The electrode arrangement is 
generally enclosed in a chamber to introduce various gas mixtures between the two 
electrodes [16]. High voltages sources with frequencies in the kHz range generally 
drive DBDs. There are many different configurations of DBD are available, but the 
concept behind them all is the same. These include planar, parallel plates separated 
by a dielectric or a cylinder, or coaxial plates with a dielectric tube between them. 
Some basic DBD electrode configurations are shown in Figure 4.
More recently, Fridman et al. developed a floating electrode DBD (FE-DBD) 
[17]. It is similar to the original DBD and consists of two electrodes: an insulated 
high voltage electrode and an active electrode. The difference between FE-DBD and 
DBD is that the second electrode is active, meaning it is not grounded. The second 
electrode can be human skin, a sample, or any other target. Here, the powered elec-
trode needs to be close to the surface of the second electrode to create the discharge.
The discharge in a DBD at atmospheric pressure is generally non-uniform 
filamentary type which can result in non-uniform treatment of the sample. 
The dynamic distribution of these filaments determines the appearance of the 
discharge. Although DBDs usually produce filamentary plasmas, under certain 
conditions, homogeneous diffuse plasma can also be created. Several groups have 
reported successful production of diffuse homogeneous atmospheric pressure glow 
DBD plasmas [18–21]. The mechanism of generating a glow DBD is to initiate a 
Townsend breakdown instead of a streamer breakdown [22]. To form an avalanche 
under a lower electric field and avoid growing a large number of positive space 
charges, sufficient initial seed electrons should exist in the gap before breakdown. 
Figure 4. 
Schematics of DBD with different electrode configurations.
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Figure 5. 
Typical electrode configurations of (a) DFE jet, (b) DBD jet, (c) DBD-like jet and (d) SE jet. H.V. = high voltage.
In DBDs, residual species from the previous half period of the applied voltage 
provide the seed electrons or enhance the initial field for the next discharge cycle. 
This is the so-called memory effect [19].
3.2 Atmospheric pressure plasma jet
One of the most versatile techniques for the generation of CAP plasma for 
biomedical application is the nonthermal atmospheric pressure plasma jets. Because 
of their practical capability to produce plasmas that are not spatially bound or 
9
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confined by electrodes, they can be used for direct treatment on any object irre-
spective of their shape and size. As a result, they can deliver the plasma generated 
essential short lifetime active radicals and charged particles to the sample to be 
treated. Many plasma jets with different configuration have been reported in the 
literature to generate CAP plasma. There exist various classifications schemes for 
CAP plasma jets. Some authors classify CAP plasma jets according to the power 
sources’ excitation frequency to generate the plasma. This frequency range can vary 
from DC to GHz. Accordingly, they are named DC plasma jet, pulsed-dc plasma jet, 
KHz operated plasma jet, RF operated plasma jet and Microwave driven plasma jet 
[16, 23–25]. Some authors also use the names ‘plasma flame’, ‘plasma plume’, ‘plasma 
gun’, ‘plasma stream’, ‘plasma pencil’ etc., for plasma jets [24]. The plasma jets are 
operated with inert gases such as helium, argon etc. or a mixture of inert gas and 
a few percent of reactive gases of interest. The earliest known CAP plasma jet was 
developed by Koinuma et al. in 1992. It was powered by an RF source [26].
A comprehensive collection of various types of nonthermal plasma jet arrange-
ments has been discussed in detail by Lu et al. [27]. They are classified into four 
different groups, namely dielectric-free electrode (DFE) jets, dielectric barrier 
discharge (DBD) jets, DBD-like jets and single electrode (SE) jets. The DFE jets 
consists of an inner powered electrode and an outer grounded electrode, as shown 
in Figure 5(a). There is no dielectric material between the two electrodes. The gas 
temperature of this jet is relatively high, and cooling water is needed for continuous 
operation and to keep the temperature low. There is always a risk of arcing in this 
jet when standard operating conditions are not met. The DFE jet is not suitable for 
direct biomedical applications. However, it is effective for surface sterilization. It is 
operated by an RF power source.
In DBD jets, a dielectric layer is present between the two electrodes, and the 
plasma is not in contact with any electrode. The power consumed by this plasma 
jet is very less (of the order of few watts). Due to the presence of dielectric, these 
plasma jets are relatively safe as there is no risk of arcing and is ideal for biomedical 
applications. The DBD jets can be powered by a KHz ac source or by a pulsed-dc 
source. Figure 5(b) shows the typical electrode configurations of DBD jets.
In DBD-like plasma jets, the discharge is more or less DBD-like when plasma is 
not in contact with any object. There is no dielectric material between the live elec-
trode and the object to be treated. In this type of plasma jets, easily more power can 
be delivered to the plasma, and the plasma can be very reactive. As long as arcing 
can be avoided, this type of jets has their own advantages. For biomedical applica-
tions, this kind of devices should be handled carefully because of the risk of arcing. 
These plasma jets can be powered by KHz ac, RF or pulsed dc sources. The typical 
configuration of a DBD-like plasma jet is shown in Figure 5(c).
The SE jets are similar to DBD-like jets, except there is no electrode outside the 
dielectric tube. These jets can be operated by dc, KHz ac, RF or pulsed dc power 
sources. These kind of jets are not suitable for biomedical application due to the risk 
of arcing. Figure 5(d) shows the basic electrode configuration of a SE plasma jet.
Although the plasma produced by CAP plasma jets looks homogeneous to the 
naked eye, it is actually discrete in nature when observed by using fast imaging. The 
plasma volume consists of some “bullet “-like structure, with a propagation speed 
of more than ten kms−1. This discrete nature of plasma jet was first reported by 
Teschke et al. using an RF-driven plasma jet [28] and by Lu et al. using a pulsed dc 
plasma jet [29].
3.3 Corona discharge
A corona discharge is a well-known non-equilibrium discharge that occurs 
around a pin or thin wire electrode where the electric field is higher near the 
Plasma Science and Technology
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electrode edge but decreases quickly with increase of distance [18, 30]. Due to 
this highly non-uniform electric field, the gas breakdown occurs near the pointed 
electrode. The electric field strength is high enough to form a conductive region but 
insufficient to cause electrical breakdown to nearby objects. This type of non-uni-
form electric field can be created using an asymmetric electrode pair arrangement 
such as point to plane or wire to cylindrical electrodes, as shown in Figure 6.
The corona discharge can be classified into two types depending on the polarity 
of the HV electrode. The physics of these positive and negative corona discharge 
is considerably different. This happens due to the vast difference in the mass of 
electrons and ions. In the positive corona, the electrons are attracted to the HV 
electrode, and the positive ions are repelled. The secondary electrons are created 
by photoionization in the gas near the electrode. The electrons are then attracted 
towards the electrode, which begins the process of further electron avalanche 
through inelastic collision with neutral gas molecules.
On the other hand, in the negative corona, the electrons move away from the HV 
electrode. In this case, the secondary electrons are primarily generated by the photo-
electric effect from the electrode surface itself. The process is similar to the Townsend 
breakdown. The electron avalanche then multiplies through impact ionization. As we 
go away from the electrode, positive ion accumulation occurs, and the electric field 
becomes weak. As a result, ionization diminishes there.
A corona discharge can be driven by direct-current (DC), alternating-current 
(AC), or pulsed voltage. It has widespread applications in various fields, such as 
ozone synthesis, material processing, water purification, electrophotography, 
copier machine, bacterial inactivation, wound healing and medical surface prepa-
ration etc. This type of plasma provides substantial flexibility in treating various 
products and materials used in the medical industry, for example, syringe barrels, 
pill bottles, catheter tubing, IV tubes and surgical gowns etc.
4. Diagnostics of CAP plasma
Due to the small size and transient discharge behavior of CAP plasma, plasma 
diagnostics is very challenging. The use of invasive diagnostic techniques such as 
Langmuir probe is not suitable as they significantly disturb the plasma and, as a result, 
yield incorrect values. Therefore, various non-invasive optical diagnostic techniques 
are the choices of interest for determining the plasma characteristic of CAP plasma 
[31]. One such most widely used technique is Optical emission spectroscopy (OES).  
Figure 6. 
Typical electrode configurations of corona discharge. (a) Point to plane and (b) wire to cylinder configuration.
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It is a relatively simple and easy to implement method for determining various plasma 
properties. The light emitted by the plasma due to deexcitation contains various valu-
able information regarding the plasma. An optical emission spectrometer can capture 
this radiation, from which one can extract information on the different species present 
in the plasma. Also, using the emission spectrum, one can estimate various plasma 
parameters such as electron/excitation temperature, neutral or heavy particles gas 
temperature, electron density, concentration of different reactive excited species etc. 
Figure 7 shows a typical emission spectrum obtained from an argon CAP plasma jet.
The emission spectrum of CAP plasma often contains emission from molecular 
species like 2 2, ,N N OH
+  etc. The highly energetic electrons of plasma can easily 
transfer their energy to the low lying molecular rotational and vibrational states. In 
atmospheric pressure condition, the rotational and translational degrees of freedom 
of gas molecules remain in equilibrium through collisions. Consequently, the 
rotational temperature gives the value of gas temperature. Generally, the OH  
rotational band around 306–309 nm, the second positive system of 2N  and the first 
negative system of 2N
+  are used to obtain the gas temperature. From the best fit 
between the experimental spectrum and a simulated theoretical spectrum of a 
particular molecular band, the rotational temperature or the gas temperature of the 
plasma can be determined. The simulated spectrum can be calculated using soft-
ware like Specair [32] and Lifbase [33]. The Boltzmann distribution of the rotational 
levels is assumed to obtain the temperature.
Another important plasma parameter, the electron/excitation temperature, can 
be obtained using the Boltzmann plot technique [34]. In this technique, the spectral 
line intensity (I) and the excitation temperature (Texc) is related by the formula: 
( )ln / /k k excI g A E kT Cl = - + , where λ is the wavelength of the line, gk is the upper 
state degeneracy, Ek is the upper level energy and A is the transition probability. If 
the Boltzmann law is satisfied, the plot of ( )ln / kI g Al  vs. kE  becomes a straight 
line, and the inverse of the slope gives the excitation temperature. Typically, the 
electron temperature is found to be near 1 eV in CAP plasmas. In low-temperature 
plasmas, the low energy electron number is much higher than that of high energy 
electrons. So the bound electrons on the higher excited levels can be in collisional 
equilibrium with the free electrons because the energy difference between higher 
excited levels and the ionization energy is small. So they can satisfy Boltzmann law. 
Figure 7. 
Emission spectrum of an argon CAP plasma jet.
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The population of electrons on the lower excited levels usually do not satisfy the 
Boltzmann law because they are not in collisional equilibrium with the free elec-
trons. The excitation temperature can also be measured using another well-estab-
lished method called the line intensity ratio method [35].
The electron density can be measured from the study of spectral line broaden-
ing. Spectral lines are always affected by various broadening mechanisms, such as 
Stark, Van-der-Waals, instrumental, Doppler broadening etc. By extracting the 
Stark part from the total broadening, the electron density can be determined. The 
popular lines used for this measurement is the hydrogen Balmer lines. These lines 
can appear as an impurity from the moisture, or hydrogen can be added in a small 
amount to the discharge for diagnostic purposes. The Hβ 486.13 nm line is most 
widely used because of very strong Stark broadening and less self-absorption. 
It is also not much affected by broadening due to ion dynamics and temperature 
variations. Electron density as low as 5 × 1013 cm−3 can be measured using this 
method [31]. The Hα line at 656.3 nm can also be used for this purpose. However, 
the accuracy of the electron density value obtained from this line is relatively 
less. Other non-hydrogenic atomic lines can also be used to determine the elec-
tron density using this technique. For a detailed discussion on electron density 
measurement from the Stark broadening, an interested reader can go through 
the references [36, 37]. Typically, the electron density can vary between 1010 and 
1014 cm−3 in CAP plasmas [31].
Apart from OES, there are many other techniques to study CAP plasmas. The 
active laser spectroscopy techniques such as laser induced fluorescence (LIF), 
two-photon absorption laser induced fluorescence (TALIF) can be used to obtain 
information on the ground state and long-lived, nonradiative excited atoms, 
molecules or radicals [2]. This technique has been used for many years for plasma 
diagnostics. Popular laser sources used in LIF are the Nd:YAG laser, dye lasers, 
excimer lasers, and ion lasers. Other well-known techniques such as Thompson 
scattering can give direct information on the electron density and temperature. 
Rayleigh and Raman scattering can provide information on the gas density and 
temperatures. The optical absorptions spectroscopy and cavity ring down spec-
troscopy (CRDS) can determine the absolute densities of certain plasma species. 
Other techniques known from chemical analysis such as UV and FTIR absorption 
spectroscopy, mass spectrometry, gas chromatography or electron paramagnetic 
resonance spectroscopy etc., are also used to identify and quantify ions and reac-
tive species in the plasma and to track its transition from plasma phase to liquid 
phase [6, 18, 38].
5. Effects of CAP plasma on biomaterials
The bactericidal property of plasma was first demonstrated in the mid-1990s, 
and that started a new research field combining plasma physics and medicine, i.e. 
plasma medicine [39]. From the very beginning, it was realized that the plasma 
generated reactive species play a pivotal role in the observed biological effects of 
CAP plasma. With time, our knowledge of the mechanism of plasma action on 
cells and tissues has started growing significantly. The basic understanding of the 
mechanisms of CAP plasma effects on biomaterials is crucial to establish plasma 
technology application in the biomedical field.
Notwithstanding the use of different plasma sources, working gases, micro-
organism stains, cell types etc., some general biological plasma effects have been 
mentioned repeatedly in the basic research of plasma biomaterial interactions 
such as [9, 18]:
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1. Lethal plasma effects
a. Inactivation/killing of microorganisms
b. Inactivation or destruction of cells by initialization of apoptosis in mamma-
lian cells
2. Non-lethal plasma effects
a. Stimulation of microorganism metabolism
b. Detachment of cells from the cell cluster
c. Influence on angiogenesis and cell proliferation and consequently promote 
wound healing and tissue regeneration
d. Influence on cell migration, expression of cell surface proteins
The possibility to inactivate microorganisms on sensitive surfaces of living 
structures like intact or wounded skin has attracted the very early interest of physi-
cians. The in vitro and in vivo results of plasma assisted wound healing showed that 
plasma acts in a two-stage process. The first one is the antiseptic effect to restore 
the physiological potential of the wound area by decreasing bacterial load, and the 
next one is additional stimulation of the healing processes by tissue regeneration 
independent from antiseptic effects.
Based on the current state of knowledge on the mechanism of plasma biomate-
rial interaction, it can be deduced that the biological effects of CAP plasma are 
based on two principles:
1. Biological plasma effects are primarily initiated by plasma induced changes of 
the liquid environment of tissue and cells.
2. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated 
in or transferred into liquid phases play a vital role in plasma-induced biological 
responses.
The biologically important ROSs include superoxide ( 2O
- •), hydrogen peroxide 
( 2 2H O ), hydroxyl radical (•OH ), singlet oxygen (
1
2O ), ozone ( 3O ) etc. The RNSs 
include nitric oxide (• NO ), nitrogen dioxide (• 2NO ), nitrogen trioxide ( 3NO ), 
peroxynitrite (ONOO −) etc. [7]. These reactive species are formed either by 
plasma–liquid interaction or by plasma–air interaction. These reactive species act 
on cells and tissues in the same way as that occur in the body’s regular biochemical 
and physiological processes [40]. Based on this fundamental insight, the field of 
redox biology can now be used to explain the biological plasma effects. For exam-
ple, hydroxyl radical causes peroxidation of unsaturated fatty acids present in lipids 
constituting the cell membrane. The strong oxidative properties of hydrogen 
peroxide affect proteins, lipids and DNA. Nitric oxide is known to affect the 
regulation of collagen synthesis, cell proliferation, regulation of immune deficien-
cies, induction of phagocytosis and angiogenesis etc. In cancerous cells, it is sus-
pected that the action of CAP plasma increases intracellular ROSs, which can  
lead to cell cycle arrest at the S-phase, DNA breaks, and induction of apoptosis 
(programmed cell death). Researchers have also shown that the plasma generated  
ROS and RNS can penetrate biological tissues up to more than 1 mm depth. 
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Therefore they can interact with the cells on the surface as well as with those 
beneath [41]. As these ROSs and RNSs regularly occur in cell biological processes, 
mammalian cells have mechanisms to protect themselves from over-concentration 
of these species, which might otherwise lead to oxidative stress with severe biologi-
cal consequences such as genotoxic DNA changes. Detailed investigations till now 
indicate that the application of CAP plasma does not increase the risk of genotox-
icity [6].
Other plasma components such as UV radiation, electric field/electric current 
also play an additional role. However, the role of UV in direct biological effects is 
estimated to be very low due to the low dose of UV in these plasma devices. But its 
supporting role in reactive species generation is essential. Electric fields or currents 
have varying direct biological effects on living tissue, and it strongly depends on the 
type of discharge. The magnitude of these electric fields can be as high as several 
kV/cm, and they are suspected of playing a part, such as in cellular electroporation, 
which may help larger molecules to enter the cells. Besides these, the plasma gener-
ated charged species such as electrons and ions are also assumed to play some roles 
in the observed biological effects. More research is needed to identify the role of 
these plasma components for their possible part in biological and medically relevant 
plasma action, above all reactive species.
6. Applications of cold atmospheric plasma in medicine and healthcare
CAP plasma can be employed in two different ways in biomedical applications. 
The first one is termed direct exposure or direct treatment, where plasma comes in 
direct contact with the biological sample to be treated. In this mode, all the plasma 
generated species, both long lived and short lived species, come in direct contact 
with the sample and work synergistically. The second mode is termed indirect 
exposure or indirect treatment. In this method, plasma is used to activate a liquid 
medium, and then the plasma activated liquid (PAL) is used for treatment. In 
this case, only the long lived chemical species such as nitrates, nitrites, and H2O2, 
which diffuse and solvate into the aqueous state, play a role. One advantage of PAL 
is that it can be stored and used at a later time and the composition may be tuned. 
Both types of CAP plasma treatment have shown significant success in biomedical 
applications. However, the amount of research reported using direct treatment is 
more than that using indirect treatment method.
Nowadays, CAP plasma has been successfully applied in various biomedical 
applications, including inactivation of microorganisms, sterilization of infected tis-
sues, blood coagulation, skin regeneration, tooth bleaching, wound healing, cancer 
therapy etc. CAP plasma treatment for regenerative processes, such as wound 
healing, is one of the most advanced applications of plasma technology in the 
biomedical field. Three plasma devices have already been CE certified for medical 
use. The very first one is the medical device kINPen® MED (INP Greifswald/neop-
las tools GmbH, Greifswald, Germany). The second one is PlasmaDerm® VU-2010 
(CINOGY Technologies GmbH, Duderstadt, Germany), and the latest one is the 
SteriPlas medical device (Adtec Ltd., London, United Kingdom). Their specific pur-
pose is wounds and skin diseases treatment. However, several more plasma devices 
are awaiting possible certification for clinical application [10, 42].
6.1 Use of CAP in disinfection, wound healing and dermatology
In the beginning, CAP plasma in medicine was applied to the treatment of 
chronic wounds [43]. Isbary et al. in 2012 first reported about the clinical trials 
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of CAP plasma treatment on chronic ulcer wounds [44]. The authors reported 
significant infection reduction without any side effect. After that, several clinical 
trials have proven that CAP plasma action sufficiently reduces the bacterial load 
on wounds and improve chronic ulcer healing [42]. CAP treatment is also found to 
accelerate the rate of wound closure at early stages after wounding. Various stud-
ies have shown that CAP plasma is an effective tool for disinfection of a variety of 
bacteria and fungi on the skin and wound pathogens such as Methicillin-resistant 
Staphylococcus aureus (MRSA), Escherichia coli, Pseudomonas aeruginosa etc. [45].
Besides wound healing, the CAP plasma has also been investigated in dermatologi-
cal applications. These include treatment of infective and inflammatory skin diseases 
like atopic eczema herpes, zoster, athlete’s foot, acne and others [42, 45]. Some stud-
ies have reported positive effects of CAP plasma, but still, more research is required 
to understand the biochemical processes involved in dermatological applications.
6.2 Use of CAP plasma in Cancer therapy
Another most exciting and promising area of CAP plasma application in 
medicine is cancer treatment. Cancer cells appear to be more vulnerable to CAP 
plasma than healthy cells. Researchers have shown that CAP plasma can induce 
programmed cell death (apoptosis) in cancerous cells while leaving their nearby 
healthy cells essentially unaffected. Up until various in vitro and in vivo studies have 
been performed to study the CAP plasma effect on different cancer cells. These 
studies have repeatedly shown the anti-cancer capacity of CAP plasmas.
It has been reported that CAP plasma treatment increases intracellular ROS 
concentration. This, in turn, creates a severe redox imbalance in cancer cells as they 
are already under oxidative stress. Then, the redox imbalance leads to mitochondrial 
dysfunction, DNA damage, advanced state of oxidation of proteins, caspase activa-
tion, etc., and ultimately leads to death of cancer cells [11].
The early animal studies performed had shown the promising potential of 
CAP plasma in cancer therapy [46, 47]. Since then, many in vivo studies have been 
conducted, and similar positive results have been reported for various types of 
cancer cells injected under the skin of mice. To date, CAP plasma treatment has 
demonstrated a significant anti-cancer effect on approximately twenty cancer types 
in vivo. These cancer cell lines include skin, brain, head and neck, breast, leukemia, 
hepatoma, colorectal, bladder, cervical, lung etc. [48]. In 2019, Metelmann et al. 
reported the first clinical trials on patients with advanced head and neck cancer 
[49]. The trial demonstrated the clinical relevance of CAP plasma in cancer treat-
ment and reported an overall positive effect. Some other researchers have shown 
that some radiation-resistant and chemo-resistant cancer cells are also sensitive 
to plasma treatment. Some studies have demonstrated CAP plasma as an intra-
operative adjuvant treatment. It can be used to inactivate the remaining cancer 
cells after a surgery [42, 50]. In the USA, the Food & Drug Administration (FDA) 
approved the first clinical trials of CAP plasma to treat the cancer tumors remaining 
after surgery in 2019 [11].
6.3 Use of CAP plasma in dentistry
Another long time studied field of CAP plasma application is in dental medicine. 
The most predominant oral diseases are caries and periodontitis, which are initi-
ated by dysbiotic biofilms. The application of plasma primarily aims to reduce these 
biofilms on tooth substances and surrounding tissues. Also, instead of using an 
antimicrobial solution to oral cavity sites for disinfection, CAP plasma treatment 
can eliminate the unpleasant side effects from anti-microbial solution use. There 
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is a broad spectrum of research going on the possible oral and dental application 
of CAP plasma ranging from disinfection of root canals, inactivation and removal 
of biofilm on teeth, treatment of infections and wounds of oral mucosa, dentures 
and on dental implants, tooth whitening, decontamination and coating of dental 
prosthesis, cleaning and optimization of tooth and implant surfaces to improve 
bonding of dental fillings [10, 42].
6.4 Use of CAP plasma in other biomedical areas
Another field explored from the beginning of plasma medicine research is CAP 
plasma use for hemostasis and blood coagulation [42]. Application of CAP plasma 
leads to blood coagulation in a much localized manner without damaging the tissue. 
Therefore it can be a valuable supporting technique in surgery. Aside from these 
large fields, the potential of CAP plasma in ophthalmology [51, 52] and neurology 
[53, 54] is also under investigation.
7. Summary and future outlook
The application of CAP plasma technology in the biomedical field has opened 
up new frontiers in science and technology. It has reached new heights of scientific 
progress in recent years and has been successfully applied in numerous applica-
tions, ranging from sterilization to wound healing to killing cancers. Three CAP 
devices have already been certified for clinical use for the treatment of chronic and 
infected wounds. Even if many details regarding the mechanism of interaction of 
plasma with biological matter are still not clear, some basic principles are known. 
The biological and medically beneficial plasma effects are primarily triggered by 
the plasma generated reactive oxygen species (ROS) and reactive nitrogen species 
(RNS). While CAP plasma has already reached standard medical care status in 
some areas, such as sterilization, disinfection, wound treatment etc., only primary 
and pre-clinical data for its effects are available in some other areas. A better 
understanding of the mechanism of its action will allow further improvement and 
extensions of the CAP plasma technology to achieve its full therapeutic potential. 
Also, the development of new plasma devices and modifications of the existing ones 
will open up new opportunities. In this case, international standardization of the 
methods to characterize the plasma devices is required to allow better comparability 
of results obtained from different findings.
It cannot be hypothetically omitted that CAP plasma application does not have 
some minimal adverse consequences at the molecular level. All these findings and 
the odds are subject to ongoing investigations, but the current results indicate that 
the various benefits of CAP plasma outweigh the unproven negative effects. What 
we all foresee is that the CAP plasma is on its way to clinical routine. Essentially a 
multidisciplinary research platform is growing with experts from many different 
fields like plasma physics, biochemistry, molecular biology, medicine etc. to address 
the issues with synergetic approach.
In the 20th century, laser technology caused a medical revolution with swift 
development. It successfully got integrated into medicine and created its own 
medical field called laser medicine. Now, CAP plasma has the chance to repeat 
this history and to be at the forefront of scientific and technological progress in 
medicine of the 21st century.
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